GNH USA

Europe — EMA

Omeprazol Polpharma (Omeprazole Sodium)

GNH USA supplies Omeprazol Polpharma (Omeprazole), a proton pump inhibitor for peptic ulcer disease, GERD and prevention of NSAID‑induced ulcers.

Omeprazole Sodium

Request sourcing

1
Pack/s

What is Omeprazole Sodium?

Omeprazole, the active ingredient in Omeprazol Polpharma, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It reduces gastric acid secretion and is employed to treat peptic ulcer disease, gastro‑oesophageal reflux disease, Zollinger‑Ellison syndrome and to prevent NSAID‑induced gastric ulcers.

GNH USA supplies Omeprazol Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Omeprazole Sodium used for?

Omeprazol Polpharma, a proton pump inhibitor, acts on conditions driven by excess gastric acid. - Peptic ulcer disease: lowers acid to promote ulcer healing. - Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms by decreasing acid exposure. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid. - Prevention of NSAID‑induced gastric ulcers: safeguards the gastric mucosa during NSAID therapy.

What are the side effects of Omeprazole Sodium?

Omeprazol Polpharma may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring during therapy. - Nausea: feeling of sickness or upset stomach. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Anaphylaxis: life‑threatening allergic reaction. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Neutropenia: low neutrophil count increasing infection risk. - Thrombocytopenia: reduced platelet count causing bleeding. - Interstitial nephritis: kidney inflammation.

What precautions apply to Omeprazole Sodium?

Before initiating therapy, consider the following precautions. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic disease: use with caution; assess liver enzymes regularly. - Elderly patients: start at lower doses and observe for adverse effects. - Concomitant medications: review for potential drug interactions. - Pregnancy and lactation: safety not established; weigh benefits against risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Omeprazole Sodium interact with?

Omeprazol Polpharma can affect the pharmacokinetics of several drugs.

Major Interactions (Avoid): - Clopidogrel: omeprazole reduces antiplatelet activity, increasing cardiovascular risk. - Atazanavir: decreased absorption leading to reduced antiviral efficacy. - Ketoconazole: reduced serum levels, compromising antifungal effect.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR, requiring closer coagulation monitoring. - Methotrexate: elevated levels can enhance toxicity. - Digoxin: increased serum concentration may necessitate dose adjustment.

Frequently asked questions

What conditions is Omeprazol Polpharma used to treat?+
Omeprazol Polpharma is indicated for the management of peptic ulcer disease, gastro‑oesophageal reflux disease (GERD), Zollinger‑Ellison syndrome, and for the prevention of gastric ulcers associated with non‑steroidal anti‑inflammatory drug (NSAID) therapy. It works by reducing gastric acid secretion, which helps heal ulcers and alleviate reflux symptoms.
How does omeprazole work in the body?+
Omeprazole belongs to the proton pump inhibitor class. It irreversibly inhibits the H+/K+ ATPase enzyme, also known as the gastric proton pump, located on the secretory surface of parietal cells. This inhibition blocks the final step of acid production, leading to a sustained increase in gastric pH and reduced acid‑related damage.
What is the usual dose of Omeprazol Polpharma?+
The dosage of Omeprazol Polpharma is determined by the prescribing healthcare professional based on the specific indication, severity of the condition, patient weight, renal and hepatic function, and other clinical factors. The prescriber will set the appropriate dose and infusion rate for each individual patient.
Is Omeprazol Polpharma safe during pregnancy or breastfeeding?+
Safety data for omeprazole in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss potential risks with the patient.
How do I order Omeprazol Polpharma from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including cold‑chain if required), and necessary import documentation.
How does Omeprazol Polpharma compare with other acid‑reducing drugs?+
Omeprazol Polpharma, as an intravenous proton pump inhibitor, offers rapid and potent suppression of gastric acid compared with oral PPIs or H2‑receptor antagonists. Its IV route is advantageous in patients who cannot take oral medications, have severe ulcer disease, or require immediate acid control, whereas oral agents are generally used for maintenance therapy.
What are the storage and handling requirements for Omeprazol Polpharma?+
Omeprazol Polpharma should be stored at 2‑8 °C in a refrigerator. Keep the solution in its original container, protect it from light, and avoid freezing or shaking. Do not use the product if it appears discolored or if the storage temperature has been exceeded.
How is Omeprazol Polpharma administered?+
The product is supplied as an intravenous solution and is administered by slow infusion into a vein, typically through a peripheral or central line. Administration should be performed by qualified healthcare personnel in a clinical setting, following the prescribing information for infusion rate and duration.
What are the most serious risks associated with Omeprazol Polpharma?+
Serious adverse reactions, although rare, include Clostridioides difficile‑associated diarrhea, severe allergic reactions such as anaphylaxis, hepatic dysfunction, neutropenia, thrombocytopenia, and interstitial nephritis. Patients should be monitored for signs of infection, liver injury, blood count changes, and allergic responses during therapy.
Who should not use Omeprazol Polpharma?+
Omeprazol Polpharma is contraindicated in patients with known hypersensitivity to omeprazole or any component of the formulation. Caution is advised for individuals with severe hepatic impairment, those receiving clopidogrel, and patients with a history of allergic reactions to proton pump inhibitors. The prescriber should assess suitability before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Omeprazole Sodium
Route
Intravenous Use
Manufacturer
Zaklady Farmaceutyczne Polpharma S.A.
Origin
EU

Related products

Candazol

Candazol

Omeprazole Sodium

Verisfield S.M.S.A
EU
Eselan

Eselan

Omeprazole Sodium

Anfarm Hellas Sa
EU
Eselan

Eselan

Omeprazole Sodium

Anfarm Hellas Sa
EU
Esopraz

Esopraz

Omeprazole Sodium

Lyofin Ltd, Greece
EU